Sterile Injectable CDMOs

Cardinal Health Clinical Supply Services is a division of Cardinal Health providing contract manufacturing and pharmacy solutions for biopharmaceutical companies. The company offers clinical supply services, sterile injectable manufacturing, and radiopharmaceutical contract manufacturing, with 39 FDA-registered facilities and extensive commercial-scale production capabilities.

CordenPharma is a full-service CDMO providing integrated development and manufacturing of APIs, drug products, and lipid excipients across a global network of cGMP facilities in Europe and North America. The company offers capabilities spanning peptides, oligonucleotides, highly potent and oncology compounds, small molecules, injectables, lipid nanoparticles (LNPs), and oral solid dosage forms. CordenPharma is investing over EUR 500M in a new peptide manufacturing facility in Muttenz, Switzerland, and expanding its Colorado site for large-scale peptide production.

Domixtar Pharmaceuticals SpA

Italy

Domixtar Pharmaceuticals (DMX Pharma) is Italy's largest CDMO, formed from the merger of Doppel Farmaceutici and Mipharm, and part of the group that includes Alfa Omega for nutraceuticals. With 1,000 professionals serving 105 partners across 30 countries, they offer full-service outsourcing from formulation development through post-marketing, including production, packaging, R&D, logistics, and quality control for pharmaceutical products.

Eromol UK Ltd (Eramol)

United Kingdom

Eramol (formerly Eromol UK Ltd) is a UK-based CDMO specializing in bespoke clinical trial manufacturing services, founded by two Qualified Persons. The company provides end-to-end services including formulation development, primary manufacturing, clinical packaging, QP release, and global distribution from MHRA and HPRA-approved facilities, with a new sterile injectable site opening in early 2026.

Eurofins Biopharma Services (CDMO)

Australia

Eurofins Biopharma Services CDMO is a division of Eurofins Scientific offering integrated API and drug product outsourcing services across small molecules and biologics. The company provides services from early-stage development through commercial manufacturing including highly potent drug development, sterile manufacturing/fill-finish, lyophilization, and biologics development through its Alphora brand.

European Medical Contract Manufacturing (EMCM)

Netherlands

European Medical Contract Manufacturing (EMCM) is a Dutch full-service contract manufacturer and centre of excellence in developing and manufacturing sterile medicinal products for the pharmaceutical and medical device markets. The company has 2000m2 of GMP-accredited facilities with cleanrooms from class D to class A, handling liquids, suspensions, gels, and powders in ampoules, vials, pre-filled syringes, and pouches.

Euticals (now part of Curia)

France

Euticals, now part of Curia Global, is a global CDMO with over 30 years of experience in drug discovery, development, and manufacturing across small molecules, generic APIs, sterile drug products, and biologics. Curia (which acquired Euticals through AMRI) operates an extensive global network with hundreds of FDA-registered facilities and provides end-to-end services from API manufacturing through sterile fill/finish.

Evonik Industries AG

Canada

Evonik Industries AG is a global specialty chemicals company that operates as a leading CDMO for complex parenteral drug products, focusing on polymeric and lipid-based delivery systems including liposomes, nanoparticles, microparticles, implants, and LNP formulations. The company's Health Care division provides end-to-end CDMO services for small molecules, peptides, nucleic acids (mRNA, siRNA), and HPAPIs, with FDA-inspected facilities in the US and Canada and 34 FDA inspections with zero OAI outcomes.

FAMAR

Greece

FAMAR is a leading European pharmaceutical CDMO headquartered in Greece with a network of 7 production sites and 2 R&D centers across Europe, employing approximately 1,800 people. The company provides development, manufacturing, quality, regulatory, and logistics services for a wide range of pharmaceutical and consumer care products across 80+ international markets, with capabilities spanning from oral solid dose to sterile injectables and HPAPI products.

Fareva

Brazil

Fareva is a family-owned French CDMO and the largest in France, employing 13,000 people across 41 production sites in 13 countries with EUR 2.22 billion revenue in 2025. The company provides comprehensive pharmaceutical subcontracting from API manufacturing (including HPAPIs, cytotoxics, hormones, steroids, and controlled substances) to finished drug product manufacturing and packaging across oral, sterile injectable, nasal, ophthalmic, and semi-solid dosage forms.

Finecure Pharmaceuticals Limited

India

Finecure Pharmaceuticals Limited is an Indian pharmaceutical formulation company with WHO-GMP certified manufacturing facilities producing oral dosage forms and injections. The company focuses on niche therapeutic segments including cardiovascular, anti-retroviral, neurology, and anti-infectives, with a presence across India and export markets.

GENSENTA

Turkey

Gensenta (formerly Mustafa Nevzat Ilac, acquired by Amgen in 2012 and sold to Eczacibasi in 2020) is a vertically integrated Turkish pharmaceutical company with two manufacturing facilities in Yenibosna and Sekerpinar, Turkey. The company manufactures both drug products and raw materials (APIs), and has been recognized in the sterile injectable CDMO market. Gensenta is listed as part of the Eczacibasi group and produces pharmaceuticals including caspofungin.

Groupe SYNERLAB CDMO

France

Groupe SYNERLAB (now operating as Meribel Pharma Solutions) is a mid-size European CDMO with an integrated network of manufacturing sites across Europe, providing end-to-end services from API manufacturing through finished dosage forms. The company specializes in sterile multidoses, sterile and non-sterile lyophilized products, sachets, stick packs, oral solid dose, liquids, and semi-solids.

Grünenthal PRO (Grünenthal CDMO)

Chile

Duplicate entry of Grunenthal PRO (company ID 8756785b). Grunenthal PRO is the contract manufacturing arm of Grunenthal Group, operating five specialized plants with vertically integrated manufacturing from active substance to finished products. Approximately 50% of total production is for third-party clients across 100+ countries.

Grupo Azevedos (Sofarimex)

Portugal

Grupo Azevedos, operating through its Sofarimex manufacturing unit, is a Portuguese CDMO specializing in freeze-dried injectables and sterile eye drops, with over 20 years of contract manufacturing experience. The company manufactures pharmaceutical medicines and health products for third parties across non-sterile solid, semi-solid, and liquid forms, as well as sterile products, and holds manufacturing licenses from INFARMED and multiple international authorities.

Shenzhen Hybio Pharmaceutical Co., Ltd. (Hybio) is a Chinese pharmaceutical company founded in 1998, specializing in peptide drug R&D, manufacturing, and commercialization with a CRDMO division. The company focuses on peptide APIs (including semaglutide) and sterile injectable formulations, with products sold in 30+ countries. Hybio has 7 FDA-registered facilities and a strategic partnership with Dr. Reddy's for peptide API supply, and recently partnered with Huawei for AI-driven drug development.

JEWIM Pharmaceutical (Shandong) Co., Ltd. is a Chinese pharmaceutical company in transformation, focusing on innovative drugs and complex drug delivery systems including inhalation products, nasal sprays, and long-acting injectable microspheres. The company is an established CDMO/CMO partner for multinational pharma companies including Johnson & Johnson (Xian Janssen), Kenvue, and Bayer, with quality systems certified by US FDA and Australian TGA. Products are exported to over 80 countries.

Jubilant HollisterStier CMO

Canada

Jubilant HollisterStier CMO (subsidiary of Jubilant Pharma) specializes in sterile fill-finish, lyophilization, injectables, ophthalmics, otics, topicals, and liquids for pharmaceutical and biopharmaceutical clients. End-to-end services from process development to inspection and packaging. Facilities in Spokane, WA and Montreal, QC. Won AWB Manufacturer of the Year 2024 and Manufacturing Excellence Award 2025. Largest manufacturer by employees in Spokane area. 92% repeat customer rate. FDA registered with 4 FEI numbers, 28 inspections (6 NAI, 18 VAI, 4 OAI -- elevated regulatory risk).

Laboratorios Basi – Indústria Farmacêutica

Portugal

Laboratorios Basi - Industria Farmaceutica S.A. is a Portuguese pharmaceutical company whose mission is to develop, manufacture, market, and globally distribute medicines and therapeutic solutions built on European quality excellence with innovative technologies. They have over 240 pharmaceutical products registered across 17 therapeutic areas and are present in more than 60 countries. They operate two industrial units and offer contract manufacturing services for injectable products (small and large volume), gels, creams, ointments, syrups, oral solutions and suspensions, cutaneous solutions, and enemas. They also offer licensing, quality control, and R&D services. Their innovation arm operates through Basinnov.

Latitude Pharmaceuticals Inc

United States

Latitude Pharmaceuticals Inc is a San Diego, CA-based CRO/CMO (CRDMO) providing innovative drug formulation development and GMP manufacturing services. Founded in 2003, the company has completed over 900 pharmaceutical formulation development projects for 250+ client companies. Specializes in solving complex drug formulation challenges, particularly for insoluble APIs using their proprietary CLEARSOL platform. Provides GLP- and GMP-compliant manufacturing and analytical testing services for IND-enabling studies and Phase 1-2 clinical trial materials, including sterile injectables, fill/finish, lyophilization, vials, pre-filled syringes, and IV bags.

Lupin Limited (Lupin Manufacturing Solutions)

Brazil

Lupin Manufacturing Solutions (LMS) is the CDMO arm of Lupin Limited, one of India's largest pharmaceutical companies. LMS offers integrated CDMO services spanning API manufacturing, formulation development, and finished dosage form production. They operate 16 FDA-registered facilities with 512 FDA-approved products. They have recently expanded into oncology with a dedicated block at Vizag, India, and formed a strategic alliance with PolyPeptide for peptide supply chain scaling. Their extensive regulatory track record includes FDA, WHO, and multiple international approvals.

Medivant Healthcare

United States

Medivant Healthcare is a boutique, cGMP-compliant generic injectable manufacturer based in Chandler, Arizona, USA, founded in 2015. The company specializes in sterile single-dose liquid injectable vials (1 ml to 30 ml) for the US market, focusing on FDA/ASHP drug shortage list medications. Medivant operates an FDA-registered and inspected facility with a fully automated manufacturing tank (up to 240 liters under ISO 7 laminar flow), automated filling machine (up to 100 vials/minute under ISO 5), terminal sterilization with 10-log-6 overkill approach, and in-house WFI system. They serve over 300 hospitals and 10+ clinics. Medivant has a strategic partnership with Piramal Critical Care for injectables.

MoNo chem-pharm Produkte GmbH

Austria

MoNo chem-pharm Produkte GmbH is an Austrian pharmaceutical contract manufacturer founded in 2000, affiliated with Sigmapharm Arzneimittel GmbH (70+ years in healthcare). The company specializes in the development and production of all types of pharmaceutical liquids — sterile and non-sterile, aqueous, oily, alcoholic, and viscous. State-of-the-art facilities for aseptic production of sterile liquids and filling into vials. Listed on CPHI for contract manufacturing, logistics/distribution, and regulatory services.

Montage Laboratories Private Limited

India

Montage Laboratories Private Limited is an Indian pharmaceutical formulations manufacturer based in Himatnagar, Gujarat with 30+ years of experience. The company specializes in sex hormone formulations and injectables, with dedicated facilities for sex hormone injection manufacturing (ampoules, vials, pre-filled syringes) and both beta-lactam and general injectable production. FDA-registered with 3 FEI numbers and 14 FDA inspections (12 NAI, 2 VAI — excellent track record). ISO 9001:2015 and ISO 14001:2015 certified, D&B certified.

Murli Krishna Pharma Pvt Ltd

India

Duplicate entry for Murli Krishna Pharma Private Ltd. (mkppl.com) - same company, same website domain. Indian pharmaceutical CDMO specializing in PFI and FDF products with CRAMS services.

Norwich Pharmaceuticals (now Norwich Pharma Services, part of Alvogen) is a US-based contract development and manufacturing organization with over 130 years of pharmaceutical manufacturing history in Norwich, New York. The company manufactures generic medications including capsules, tablets, and extended-release tablets. Norwich is FDA-registered with operations including analysis, labeling, manufacturing, packing, relabeling, and repacking, and has 3 FDA-approved products with strong inspection history (6 NAI out of 7).

Oakwood Laboratories LLC is a US-based specialty pharmaceutical company and CDMO focused on advanced injectable drug delivery systems, particularly sustained-release and microsphere formulations. The company operates a GMP aseptic manufacturing facility in Solon, Ohio, providing contract development and manufacturing for long-acting injectable products.

Oncotec Pharma Produktion GmbH is a German CDMO specializing in the development and aseptic manufacturing of cytostatic (anticancer) drugs. Founded in 1997, the company provides full-service contract manufacturing from lab-scale development through commercial production, with approximately 2,300 m2 of cleanroom space and isolator-protected production lines at its Dessau-Rosslau facility.

Pace Life Sciences is a division of Pace Analytical Services LLC, operating as a full-service CDMO/CRO network across the United States. The company supports drug development across the entire lifecycle from preclinical research through commercialization, specializing in small molecules, biologics (proteins, peptides, monoclonal antibodies, ADCs), nucleic acids (oligonucleotides, mRNA, plasmid DNA), and gene therapies. Recognized by PharmaSource as a Top CDMO in the United States. Operates 9+ strategically located sites including a sterile fill-finish Center of Excellence in Salem, NH.

PharmIdea is a Latvian CDMO located in Olaine, Latvia, specializing in sterile drug development, commercial production, and worldwide supply of pharmaceutical products. The company focuses on sterile drugs in vials, offering contract manufacturing services including product development. PharmIdea has completed CTDs for out-licensing and provides contract manufacturing of sterile injectables such as Levosimendan concentrate for solution for infusion (small batch), Caspofungin, and Carbetocin. The company has partnered with Lidds for manufacturing NZ-TLR9 formulation against solid tumors.

Recordati is an Italian pharmaceutical company with both a proprietary product business (rare diseases, specialty/primary care) and a fine chemicals/CDMO division. Recordati Fine Chemicals (also known as Recordati Industria Chimica e Farmaceutica) provides contract API manufacturing. They have FDA-registered facilities, 26 approved products across multiple dosage forms, and significant industrial operations. The fine chemicals division offers API development and manufacturing services to third-party pharmaceutical companies.

Reliance Life Sciences (RLS), part of Reliance Industries, is a premier Indian biotechnology company providing contract manufacturing and development services across pharmaceuticals and biosimilars. They have FDA-registered manufacturing facilities with 7 FDA-approved products (injectables, powders, tablets). Their capabilities span API manufacturing, formulation development, biologics/biosimilar manufacturing, and cell and gene therapy R&D. They are a vertically integrated biotech company with 1,000-5,000 employees, offering CDMO services alongside their own product portfolio.

SEDICO Pharmaceutical Company is an Egypt-based pharmaceutical manufacturer and API producer, providing contract manufacturing (CMO/CDMO) services. The company manufactures a broad range of pharmaceutical products including oral solids, injectables, and various dosage forms. SEDICO has recently entered oncology drug production through a partnership with Sandoz Global to localize oncology pharmaceutical products in Egypt.

DUPLICATE ENTRY: This is the same company as Standard Chem. & Pharm. Co. Ltd (companyId: 6a650983). See primary entry for full profile. Standard Chem. & Pharm. Co., Ltd. (SCP) is a Taiwanese CDMO established in 1967.

STA Pharmaceutical Co., Ltd. (WuXi STA) is a subsidiary of WuXi AppTec and one of the world's leading CDMOs, specializing in integrated CMC services for small molecule APIs and drug products (oral and injectable/sterile) from preclinical to commercial scale. They also have capabilities in oligonucleotides, peptides, and bioconjugates. WuXi STA operates 9-14 global manufacturing sites across Asia, North America, and Europe with uniform quality/EHS standards approved by major regulators. They have supported 50+ first-time drug approvals since 2017 across 105 countries. The company has 5,100+ scientists, claims 100% PPQ success rate, and serves 1,200+ customers. Their Changzhou site has passed US FDA inspection and they have a continuous manufacturing line for oral solid dose.

Sunny Pharmtech Inc. is a Taiwan-headquartered integrated specialty pharmaceutical CDMO specializing in high-potency APIs and drugs, including small molecules, peptides, and ADC linker-payloads. The company develops complex, high-barrier, niche drugs including ANDAs and 505(b)(2) filings, with state-of-the-art facilities offering OEB 5 containment and capabilities from early-stage formulation development to commercial manufacturing.

Symbiotec Pharmalab is a leading Indian manufacturer of corticosteroid and steroidal-hormone APIs with a global leadership position. With over 30 years of experience, the company has evolved from lab-scale manufacturing to industrial-scale production, operating two FDA-approved facilities (Rau and Pithampur, Indore). The company offers integrated CDMO solutions across organic chemistry, biotechnology/fermentation, and complex injectable platforms. It holds a 50%+ global market share in key steroid API molecules and serves 200+ customers in 40+ countries.

Division of Terumo Corporation (TSE:4543), a global healthcare technology leader since 1921 with 30,000+ employees. Provides sterile injectable contract development and manufacturing (CDMO) services from combination device design and formulation development to commercial manufacturing. Offers a portfolio of injection, infusion, and primary packaging solutions including PLAJEX polymer pre-fillable syringes, Immucise intradermal injection systems, hypodermic needles, and Surflo winged infusion sets. Recently expanded CDMO services outside Japan for global market and is doubling capacity.

Unither Pharmaceuticals is a global CDMO specializing in sterile and non-sterile liquid pharmaceutical forms, and the world leader in Blow-Fill-Seal (BFS) technology with annual production capacity exceeding 5 billion doses. Founded in 1993 in France, they operate 9 production sites across Europe, North America, South America, and China with 2,500+ employees. They offer contract manufacturing (clinical and commercial), formulation/analytical development, out-licensing of turnkey products, co-development partnerships, and regulatory support including CTD/eCTD submissions. Products include BFS single-doses, multi-doses, vials, sprays, stick packs, and ophthalmic solutions.

Zambon is an Italian multinational healthcare group founded in 1906 with EUR 899 million in revenues and 2,768 employees. The group operates as both a pharmaceutical company (Zambon Pharma) and a CDMO, offering contract development and manufacturing services ranging from development through commercial production. Manufacturing plants in Vicenza (Italy), Cadempino (Switzerland), Haikou (China), and Barueri (Brazil) supply 87 countries. Also includes Zach System (API custom synthesis) as its chemical division.

Chitose Bio Evolution

Japan

Chitose Bio Evolution Pte. Ltd. is a biotechnology company based in Japan and Singapore focused on zero-carbon emission through photoautotrophic microalgae production. The company works on carbon capture technology and bio-based materials rather than pharmaceutical manufacturing.

Farmak JSC

Poland

Farmak JSC is the leading pharmaceutical manufacturer in Ukraine, producing medicines for over 60 countries with more than 3,000 employees. The company offers contract manufacturing services for APIs and finished medicinal products in a wide range of dosage forms including liquids, solids, semi-solids, soft gelatin capsules, and sterile injectables, working with European and Ukrainian companies.

FUJIFILM Biotechnologies (formerly FUJIFILM Diosynth Biotechnologies) is a global biologics CDMO operating 10 facilities across the US, UK, Denmark, and Japan with over 4,800 employees. The company provides end-to-end cGMP manufacturing services for biologics, advanced therapies, and vaccines, from preclinical through commercialization, with $8.6 billion invested in recent years and 20+ commercial licenses.

Galenica S.A.

Greece

Galenica S.A. is a Greek pharmaceutical company founded in 1974, operating two EU-GMP certified and FDA-approved manufacturing facilities in Chalkida and Kryoneri. The company offers Contract Manufacturing Operations (CMO) producing injectables, solids, liquids, and semi-liquids for third parties. Galenica also markets its own prescription and OTC medicines and exports to over 18 countries.

Goodwin Biotechnology (GBI) is a full-service biopharmaceutical CDMO based in Florida, specializing in biologics development and manufacturing. Named Manufacturer of the Year by BioFlorida, GBI offers its Single-Source Solution for monoclonal antibodies, ADCs, recombinant proteins, and other complex biologics from cell line development through cGMP commercial manufacturing. The company provides mammalian cell culture manufacturing using CHO and other expression systems.

Hainan Shuangcheng Pharmaceuticals Co., Ltd. (HNSP) is a publicly-traded Chinese pharmaceutical company founded in 2000, engaged in R&D, manufacturing, and sales of pharmaceutical products with a focus on peptide APIs and injectable formulations. The company offers CDMO/contract manufacturing services representing 20-35% of revenue, and has FDA-registered facilities with multiple FDA inspection history. It operates manufacturing sites in Haikou and has invested in a Ningbo facility.

Hainan Zhonghe Pharmaceutical Co., Ltd., a subsidiary of Hainan Zhonghe (Group) Co., Ltd., is described as a leading high-tech pharmaceutical enterprise in Asia. The company manufactures pharmaceutical products including APIs and finished dosage forms such as Eptifibatide Injection, Entecavir Dispersible Tablets and Capsules, and Octreotide. It sells APIs and formulations through CPHI and other channels.

Kaisha Lifesciences Pvt. Ltd

India

Kaisha Lifesciences is a pharmaceutical company under the Dadachanji Group of Companies (30+ year heritage), offering contract R&D services from product development to scale-up, plus its own product portfolio. Part of a diversified group including Schott Kaisha (glass vials, 50% acquired by Serum Institute of India), Kaisha Packaging, and Kaisha Medisurge. WHO-GMP certified manufacturing facility for terminally sterilized and aseptically filled injectables in ampoules, vials (liquid and lyophilized), and pre-filled syringes. Departments include formulation development, analytical development, quality assurance, and regulatory affairs. Products include Enoxaparin Sodium Injection. First Indian patent approval 2021.